Despite the fact that dehydration should now be accepted as a risk factor for poor outcomes after stroke, we know very little of how its negative effects are attenuated or modified by current treatments of IS, particularly thrombolytic therapy with tissue plasminogen activator (tPA). This evidence concerns the gene PLAT and Stroke.